FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023703923> ?p ?o ?g. }

• W2023703923 endingPage "2212" @default.
• W2023703923 startingPage "2204" @default.
• W2023703923 abstract "In this work, we have developed a microfluidic cytotoxicity assay for a cell culture and detection platform, which enables both fluid handling and electrochemical/optical detection. The cytotoxic effect of anticancer drugs doxorubicin (DOX), oxaliplatin (OX) as well as OX-loaded liposomes, developed for targeted drug delivery, was evaluated using real-time impedance monitoring. The time-dependent effect of DOX on HeLa cells was monitored and found to have a delayed onset of cytotoxicity in microfluidics compared with static culture conditions based on data obtained in our previous study. The result of a fluorescent microscopic annexin V/propidium iodide assay, performed in microfluidics, confirmed the outcome of the real-time impedance assay. In addition, the response of HeLa cells to OX-induced cytotoxicity proved to be slower than toxicity induced by DOX. A difference in the time-dependent cytotoxic response of fibrosarcoma cells (HT1080) to free OX and OX-loaded liposomes was observed and attributed to incomplete degradation of the liposomes, which results in lower drug availability. The matrix metalloproteinase (MMP)-dependent release of OX from OX-loaded liposomes was also confirmed using laryngopharynx carcinoma cells (FaDu). The comparison and the observed differences between the cytotoxic effects under microfluidic and static conditions highlight the importance of comparative studies as basis for implementation of microfluidic cytotoxic assays." @default.
• W2023703923 created "2016-06-24" @default.
• W2023703923 creator A5003106491 @default.
• W2023703923 creator A5003337744 @default.
• W2023703923 creator A5010338422 @default.
• W2023703923 creator A5012302822 @default.
• W2023703923 creator A5028692100 @default.
• W2023703923 creator A5029679398 @default.
• W2023703923 creator A5034713890 @default.
• W2023703923 creator A5049590778 @default.
• W2023703923 creator A5061332627 @default.
• W2023703923 creator A5071086734 @default.
• W2023703923 creator A5076065857 @default.
• W2023703923 creator A5076237877 @default.
• W2023703923 creator A5081928372 @default.
• W2023703923 date "2015-02-04" @default.
• W2023703923 modified "2023-10-06" @default.
• W2023703923 title "Impedimetric Toxicity Assay in Microfluidics Using Free and Liposome-Encapsulated Anticancer Drugs" @default.
• W2023703923 cites W1534849470 @default.
• W2023703923 cites W1967597978 @default.
• W2023703923 cites W1971187136 @default.
• W2023703923 cites W1973121010 @default.
• W2023703923 cites W1973401399 @default.
• W2023703923 cites W1975687263 @default.
• W2023703923 cites W1978129088 @default.
• W2023703923 cites W1979260862 @default.
• W2023703923 cites W1988741714 @default.
• W2023703923 cites W1989658721 @default.
• W2023703923 cites W1992904753 @default.
• W2023703923 cites W1993958396 @default.
• W2023703923 cites W1995746991 @default.
• W2023703923 cites W2010183849 @default.
• W2023703923 cites W2012153842 @default.
• W2023703923 cites W2012998035 @default.
• W2023703923 cites W2013470095 @default.
• W2023703923 cites W2015208340 @default.
• W2023703923 cites W2016824907 @default.
• W2023703923 cites W2016915024 @default.
• W2023703923 cites W2017750460 @default.
• W2023703923 cites W2022216914 @default.
• W2023703923 cites W2022679613 @default.
• W2023703923 cites W2025998034 @default.
• W2023703923 cites W2028621596 @default.
• W2023703923 cites W2028884054 @default.
• W2023703923 cites W2032553799 @default.
• W2023703923 cites W2033023421 @default.
• W2023703923 cites W2036464893 @default.
• W2023703923 cites W2038628992 @default.
• W2023703923 cites W2040050326 @default.
• W2023703923 cites W2041612826 @default.
• W2023703923 cites W2054874597 @default.
• W2023703923 cites W2055211108 @default.
• W2023703923 cites W2059955504 @default.
• W2023703923 cites W2062409563 @default.
• W2023703923 cites W2068180754 @default.
• W2023703923 cites W2073261059 @default.
• W2023703923 cites W2075815764 @default.
• W2023703923 cites W2076226743 @default.
• W2023703923 cites W2082683737 @default.
• W2023703923 cites W2092480242 @default.
• W2023703923 cites W2094831823 @default.
• W2023703923 cites W2095116679 @default.
• W2023703923 cites W2095301069 @default.
• W2023703923 cites W2102027763 @default.
• W2023703923 cites W2106787323 @default.
• W2023703923 cites W2114918609 @default.
• W2023703923 cites W2122731269 @default.
• W2023703923 cites W2130053427 @default.
• W2023703923 cites W2136388349 @default.
• W2023703923 cites W2137634849 @default.
• W2023703923 cites W2138733574 @default.
• W2023703923 cites W2140995979 @default.
• W2023703923 cites W2146356730 @default.
• W2023703923 cites W2147977342 @default.
• W2023703923 cites W2148736140 @default.
• W2023703923 cites W2152257086 @default.
• W2023703923 cites W2152673204 @default.
• W2023703923 cites W2155685071 @default.
• W2023703923 cites W2315503416 @default.
• W2023703923 cites W2419637041 @default.
• W2023703923 cites W4230767300 @default.
• W2023703923 doi "https://doi.org/10.1021/ac503621d" @default.
• W2023703923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25582124" @default.
• W2023703923 hasPublicationYear "2015" @default.
• W2023703923 type Work @default.
• W2023703923 sameAs 2023703923 @default.
• W2023703923 citedByCount "31" @default.
• W2023703923 countsByYear W20237039232015 @default.
• W2023703923 countsByYear W20237039232016 @default.
• W2023703923 countsByYear W20237039232017 @default.
• W2023703923 countsByYear W20237039232018 @default.
• W2023703923 countsByYear W20237039232019 @default.
• W2023703923 countsByYear W20237039232020 @default.
• W2023703923 countsByYear W20237039232021 @default.
• W2023703923 countsByYear W20237039232022 @default.
• W2023703923 countsByYear W20237039232023 @default.
• W2023703923 crossrefType "journal-article" @default.
• W2023703923 hasAuthorship W2023703923A5003106491 @default.

• next